Tetrahydrofuran → (5-Bromo-imidazo[1,2-a]pyrazin-8-yl)-(3-hydroxymethyl-4-morpholin-4-yl-phenyl)-carbamic acid tert-butyl ester
Reaktionsgleichung
[C:1]([O:5][C:6](=[O:39])[N:7]([C:29]1[C:30]2[N:31]([CH:36]=[CH:37][N:38]=2)[C:32]([Br:35])=[CH:33][N:34]=1)[C:8]1[CH:13]=[CH:12][C:11]([N:14]2[CH2:19][CH2:18][O:17][CH2:16][CH2:15]2)=[C:10]([C:20](C)(C)[O:21][SiH2]C(C)(C)C)[CH:9]=1)([CH3:4])([CH3:3])[CH3:2].C1COCC1>[F-].C([N+](CCCC)(CCCC)CCCC)CCC>[C:1]([O:5][C:6](=[O:39])[N:7]([C:29]1[C:30]2[N:31]([CH:36]=[CH:37][N:38]=2)[C:32]([Br:35])=[CH:33][N:34]=1)[C:8]1[CH:13]=[CH:12][C:11]([N:14]2[CH2:15][CH2:16][O:17][CH2:18][CH2:19]2)=[C:10]([CH2:20][OH:21])[CH:9]=1)([CH3:4])([CH3:2])[CH3:3]Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
A solution of (5-bromo-imidazo[1,2-a]pyrazin-8-yl)-[3-(tert-butyl-dimethyl-silanyloxymethyl)-4-morpholin-4-yl-phenyl]-carbamic acid tert-butyl ester (0.164 g, 0.265 mmol) in 1M tetrabutylammonium fluoride in THF (0.29 mL, 0.29 mmol) is stirred at room temperature overnight. The solvent is removed under vacuum and the residue is purified by silica gel column chromatography eluting with ethyl acetate. The title compound is isolated (0.126 g, 94%).
Aufarbeitung
- customThe solvent is removed under vacuum
- customthe residue is purified by silica gel column chromatography
- washeluting with ethyl acetate
Quellen und Nachweise
- ORD-Eintrag
- ord-8df740308284487896e1e9f775dfbdeb
- Quelldatensatz
- uspto-grants-2012_05
- Patentnummer
- US08173656B2
Notizen zur Reaktion
Wird geladen…